An initiative to manufacture and characterize baculovirus reference material
Copyright policy )An initiative to manufacture and characterize baculovirus reference material
This letter to the editor brings to the attention of researchers an initiative to develop a baculovirus reference material repository. To be successful this initiative needs the support of a broad panel of researchers working with baculovirus vectors for recombinant protein production and gene delivery for either therapy or vaccination. First there is a need to reach a consensus on the nature of the reference material, the production protocols and the baculovirus characterization methods. It will also be important to define repository and distribution procedures so that the reference material is available to any researcher for calibrating experimental data and to compare experiments performed in the various laboratories. As more and more baculovirus-based products are licensed or in the final stages of development, the development of a repository of baculovirus reference material is timely. This letter describes the requirements for the reference material and for the project as a whole to be successful and calls for a partnership that would involve academic, industrial laboratories and governmental organizations to support this international initiative.
Technology, mammalian-cells, Baculoviridae/*genetics, Pharmaceutical/*standards, vectors, Baculovirus expression, vaccine, Synthetic/standards, Viral, Baculovirus, Genetic Vectors/*standards, real-time pcr, reference material, Vaccines, Vaccines, Synthetic, Genetic Engineering/methods/*standards, standard, Reference Standards, gene therapy, [SDV] Life Sciences [q-bio], insect cells, chromatography, protein production, Biological Agents/*standards, Genetic Engineering, Baculoviridae, biotechnology, titration, Gene Expression Regulation, Viral, Quality Control, Canada, gene-therapy, purification, Genetic Vectors, methods, Genetic Therapy/standards, Humans, Technology, Pharmaceutical, recombinant baculovirus, recombinant protein production, therapy, Biological Products, Genetic Therapy, Gene Expression Regulation, nuclear polyhedrosis-virus, protein, recombinant protein
Technology, mammalian-cells, Baculoviridae/*genetics, Pharmaceutical/*standards, vectors, Baculovirus expression, vaccine, Synthetic/standards, Viral, Baculovirus, Genetic Vectors/*standards, real-time pcr, reference material, Vaccines, Vaccines, Synthetic, Genetic Engineering/methods/*standards, standard, Reference Standards, gene therapy, [SDV] Life Sciences [q-bio], insect cells, chromatography, protein production, Biological Agents/*standards, Genetic Engineering, Baculoviridae, biotechnology, titration, Gene Expression Regulation, Viral, Quality Control, Canada, gene-therapy, purification, Genetic Vectors, methods, Genetic Therapy/standards, Humans, Technology, Pharmaceutical, recombinant baculovirus, recombinant protein production, therapy, Biological Products, Genetic Therapy, Gene Expression Regulation, nuclear polyhedrosis-virus, protein, recombinant protein
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).9 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!